Doctor profile · Federal record
Dr. Colleen Schrant, FNP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Tucson, AZ
- NPI 1922349729
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5150 E Glenn St
Tucson, AZ 857121337
(520) 795-7729 - Mailing address
-
11047 N Cloud View Pl
Tucson, AZ 857377070
Credentials & registration
- NPI registered
- March 2013 — 13 yrs on file
- Profile last updated
- March 10, 2026
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Arizona #F0213273
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922349729. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,345
Distinct HCPCS
10
Medicare allowed
$116,373
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 7,400 | 31 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 762 | 143 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 211 | 171 | $40 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 205 | 162 | $75 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 193 | 112 | $106 | |
17110 |
Destruction of skin growth, 1-14 growths | 156 | 130 | $95 | |
11102 |
Biopsy of related skin growth, first growth | 122 | 117 | $71 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 99 | 99 | $94 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 50 | 50 | $135 | |
11103 |
Biopsy of related skin growth, each additional growth | 40 | 23 | $42 |
In context: peer comparison
Among 198 peers in Tucson Family Nurse Practitioner, average services per provider: 231. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$1,026
Transactions
52
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 20 | $306.25 | |
| Genzyme Corporation | 7 | $173.70 | |
| Lilly USA, LLC | 8 | $134.03 | |
| Leo Pharma INC. | 5 | $111.93 | |
| Regeneron Healthcare Solutions, INC. | 4 | $98.53 | |
| Sanofi-Aventis U.S. LLC | 1 | $85.00 | |
| Pfizer INC. | 2 | $35.02 | |
| Janssen Biotech, INC. | 2 | $27.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.16 | |
| Dermavant Sciences, INC. | 1 | $19.33 | |
| Galderma Laboratories, L.P. | 1 | $13.88 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,063
Patients
674
Total drug cost
$35,069
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 351 | 207 | $7,828 |
| Clobetasol Propionate | Generic | 160 | 103 | $8,437 |
| Triamcinolone Acetonide | Generic | 93 | 74 | $1,226 |
| Hydrocortisone | Generic | 72 | 53 | $764 |
| Doxycycline Hyclate | Generic | 64 | 44 | $2,138 |
| Metronidazole | Generic | 51 | 30 | $3,992 |
| Prednisone | Generic | 44 | 32 | $290 |
| Mupirocin | Generic | 41 | 38 | $405 |
| Hydroxyzine Hcl | Generic | 40 | 24 | $566 |
| Clindamycin Phosphate | Generic | 36 | 24 | $2,004 |
Frequently asked questions
What is Dr. Colleen Schrant's medical specialty?
Dr. Colleen Schrant practices Family Nurse Practitioner in Tucson, AZ.
Where does Dr. Colleen Schrant practice?
Dr. Colleen Schrant practices at 5150 E Glenn St, Tucson, AZ 857121337. Office phone: 5207957729.
What is Dr. Colleen Schrant's NPI?
Dr. Colleen Schrant's National Provider Identifier (NPI) is 1922349729, issued by NPPES.
Does Dr. Colleen Schrant accept Medicare assignment?
Yes. Dr. Colleen Schrant accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Colleen Schrant commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.